Results

Total Results: 1,659 records

Showing results for "prostate cancer screening".
Users also searched for: psa

61. Public Comment on Draft Recommendation: Screening for Prostate Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-screening-prostate-cancer
    November 08, 2011 - Public Comment on Draft Recommendation: Screening for Prostate Cancer Share to Facebook … Preventive Services Task Force posted its draft recommendation statement on screening for prostate cancer … The draft recommendation statement may be viewed at /uspstf/recommendation/cervical-cancer-screening … Task Force members will also be holding a briefing via conference call on its draft recommendation on screening … for prostate cancer on Friday, October 14 from 3:00 to 4:00 pm, ET.

62. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/G9P7o8jDh4J3NnAk6y-SYL
    December 01, 2011 - Screening for Prostate Cancer: A Review of the Evidence for the U.S. … prostate cancers are lo- calized (6, 7, 13). … identifies more prostate cancers, but most trials found no effect on risk for death from prostate cancer … In summary, PSA-based screening is associated with detection of more prostate cancers; small to no reduction … of the Prostate Strategic Urologic Research Endeavor.

63. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
    January 01, 2010 - cancers? … Do changes in screening and management for prostate cancer resulting from use of PCA3 assays lead to … What is the cost-effectiveness of using PCA3 assays to guide screening and management for prostate cancer … Potential for clinically significant prostate cancers to be missed in individuals presumed to be at … While there are currently several guidelines addressing total PSA testing and prostate cancer screening

64. NIH State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-surveillance/research-protocol
    May 19, 2011 - Currently, most prostate cancer in men in the United States is found by prostate-specific antigen (PSA … ) screening. … It was projected that in 2010 over 217,000 men would be diagnosed with cancer of the prostate and about … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … cancer screening standards, treatment, et cetera.

65. Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
    January 01, 2016 - Therapies for Clinically Localized Prostate Cancer Therapies for Clinically Localized Prostate Cancer … The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … Prostate cancer–specific mortality: The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.

66. Public Comment on Draft Research Plan: Screening for Prostate Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-screening-prostate-cancer-0
    November 08, 2023 - Public Comment on Draft Research Plan: Screening for Prostate Cancer Share to Facebook … Preventive Services Task Force posted today a draft research plan on screening for prostate cancer.

67. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

68. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - neoplasms OR "prostate cancer" AND Limits: Meta-Analysis OR prostatic neoplasms OR "prostate cancer … neoplasms OR "prostate cancer" AND "age factors"OR age [ti] OR ethnicityOR ethnic groups OR … neoplasms OR "prostate cancer" AND "hospital volume" OR "surgeon volume" OR "clinical competence" … neoplasms OR "prostate cancer" AND caseload* OR case load* OR case volume* NUMBER OF RESULTS … neoplasms OR "prostate cancer" AND prostate-specific antigen OR "tumor characteristics" OR "tumor

69. Inaccuracies in assignment of clinical stage for localized prostate cancer. | PSNet
    psnet.ahrq.gov/issue/inaccuracies-assignment-clinical-stage-localized-prostate-cancer
    April 06, 2022 - Study Inaccuracies in assignment of clinical stage for localized prostate cancer. … Inaccuracies in assignment of clinical stage for localized prostate cancer. … However, this analysis of patients newly diagnosed with prostate cancer found that clinicians erred in … Inaccuracies in assignment of clinical stage for localized prostate cancer. … May 1, 2019 Defining, estimating, and communicating overdiagnosis in cancer screening

70. Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/prostate-cancer/

71. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

72. Public Comment on Draft Recommendation Statement: Screening for Prostate Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-screening-prostate-cancer
    May 08, 2017 - Public Comment on Draft Recommendation Statement: Screening for Prostate Cancer Share to … Services Task Force seeks comments on a draft recommendation statement and draft evidence reviews on screening … for prostate cancer. … Task Force determined that the potential benefits and harms of prostate-specific antigen (PSA)–based screening … cancer.

73. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/clinician
    January 21, 2016 - The Scandinavian Prostate Cancer Group-4 (SPCG-4) study (N = 695) and the Prostate Cancer Intervention … and reported data on prostate cancer–specific and all-cause mortality. … Prostate cancer–specific mortality : The SPCG-4 study found that RP reduced prostate cancer–specific … Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. … Prostate-specific antigen screening after 2012 US Preventive Services Task Force recommendations.

74. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Cancer of the prostate is the second most common cancer and the second leading cause of cancer deaths … The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men … Randomized Study of Screening for Prostate Cancer. … of the prostate is the second most common cancer and the second leading cause of cancer deaths in men

75. 04-E029-1 Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - screening. … Indeed, more than half of prostate cancers detected by PSA screening are expected to be early-stage, … of the Prostate Strategic Urologic Research Endeavor). … of the Prostate Urologic Research Endeavor (CaPSURE) database, 5 the National Cancer Database (NCDB) … Similarly, black patients with prostate cancer were at higher risk for death due to prostate cancer compared

76. Public Comment on Draft Research Plan: Screening for Prostate Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-screening-prostate-cancer
    November 25, 2015 - Public Comment on Draft Research Plan: Screening for Prostate Cancer Share to Facebook … Preventive Services Task Force posted today a draft research plan on screening for prostate cancer.

77. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
    April 01, 2013 - “A recent evidence review found no reduction in prostate cancer-specific mortality based on tPSA screening … Maybe it is enough to simply state that the use and effectiveness of prostate cancer screening with … This may or may not influence the sensitivity and specificity of prostate cancer screening with PSA. … cancer screening. … cancer screening.

78. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Screening for Prostate Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-screening-prostate-cancer
    May 12, 2012 - Preventive Services Task Force Issues Final Recommendation Statement for Screening for Prostate Cancer … Preventive Services Task Force released its prostate cancer screening final recommendation statement. … final recommendation statement and the supporting evidence reports, click here /uspstf/recommendation/prostate-cancer-screening

79. Therapies for Clinically Localized Prostate Cancer: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Therapies for Clinically Localized Prostate Cancer: Evidence Summary Comparative Effectiveness Review … Number 230 Therapies for Clinically Localized Prostate Cancer Evidence Summary Main Points … Prostate cancer mortality is infrequent in low-risk disease, and all-cause or prostate cancer mortality … Prostate cancer mortality and metastases were rare in all three groups. … Clinically Localized Prostate Cancer Evidence Report ECRI Institute,.

80. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - prostate cancer have cancer confined to the prostate gland or clinically localized prostate cancer … 1) Baseline PSA 2) Gleason score 3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … EAU-ESTRO-SIOG Guidelines on Prostate Cancer. … Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. … of the Prostate Risk Assessment Score CLPC= clinically localized prostate cancer EAU= European Association